Seeds

Interconnections between new biotechnologies and DSI or GSD

What are the links between new techniques of genetic modification, digitization of genetic sequences information and patents? Inf’OGM publishes here an analysis presented in June 2024 at a regional workshop organized by the African Center for Biodiversity, in Durban (South Africa). It was written by Guy Kastler, representative of the international farmers’ organization La Via Campesina at various ITPGRFA and CBD meetings. 

De Bolster: another Dutch SME under patent threat

In April 2024, Inf’OGM reported on its interview with a Dutch seed company feeling threatened by KWS patents. This is not an isolated case since De Bolster, another Dutch seed company, has had to apply constant legal vigilance for several years to prevent its varietal varieties from being covered by an ever-increasing number of patent rights, otherwise its survival would be jeopardized. Frans Carree, Director of De Bolster’s Variety Development Department, answered our questions.

“Essentially biological process”, a definition shaken up

During the parliamentary work on the proposal for a European regulation on plant reproductive material, known as the “seeds regulation”, a question arose: should so-called “non-targeted mutagenesis” be considered as an “essentially biological process”? As these processes are excluded from patentability, the question may seem important. But such a decision would not be without consequences for the regulation of GMOs.

Seed marketing reform: freeing cultivated biodiversity or patented GMOs?

EU – “Seeds”: the other proposal in the legislative package

Journal

Patents on living organisms: a growing appropriation

Journal

Intellectual property rights on living beings will be forced to evolve

Journal

Patents and evolution of the Plant Breeders’ Rights (PBRs)

Journal

Is 2024 the year when patents on life are politically challenged?